Search
for
Sort by
Research 541–570 of 1000+
- Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Eating Disorders and Diabetes: Facing the Dual Challenge
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Quality of life and willingness-to-pay in patients with androgenetic alopecia
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Empirical evidence of observer bias in randomized clinical trials: updated and expanded analysis of trials with both blinded and non-blinded outcome assessors
- Enhancing Skin Anti-Aging through Healthy Lifestyle Factors
- Staphylococcus epidermidis Cicaria, a Novel Strain Derived from the Human Microbiome, and Its Efficacy as a Treatment for Hair Loss
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- Management of psychiatric disorders with HIV and dermatological disorders
- The COVID-19 pandemic and its skin effects
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Patient characteristics associated with symptoms of anxiety, depression, and reduced body appreciation in women with polycystic ovary syndrome
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Estrogen hormone therapy stabilizes lateral hairline in transfeminine patients: Implications for facial feminization surgery
- BH07 The socioeconomic burden of alopecia areata
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Evolution and Trends of Facial Plastic Surgery and Facial Aesthetic Procedures in India: From Awakening to Revival
- The Burden of Disease in Alopecia Areata: Canadian Online Survey of Patients and Caregivers
- Androgenetic alopecia: Prevalence and clinical characteristics in a South-West Nigerian spopulation
- Lipedema and lipedematous scalp: An overview
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
- Management of Alopecia Due to Cancer Therapies
- Illness and femininity in Hilary Mantel’s Giving Up the Ghost (2003)